JANINE SHINN: Open Payments
NPI 1477975670 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,988 in 69 payments from 9 companies in 2025. Trend: 2023 $16,923 · 2024 $14,623 · 2025 $16,988
Speaker / faculty: $13,250Travel & lodging: $2,345Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $16,292 |
| Amgen Inc. | 8 | $231 |
| Novartis Pharmaceuticals Corporation | 9 | $220 |
| PFIZER INC. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Tonix Medicines, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: RINVOQ, COSENTYX, EVENITY, XELJANZ, BENLYSTA, SAPHNELO, TAVNEOS, OTEZLA.
Industry payments across TX — which companies pay providers there.
